DementiaFCSRT-TNCT05756231
Cultural and Linguistic Adaptation and Normative Study of the Turkish Version of the Free and Cued Selective Reminding Test: 16-Word Version (FCSRT-T)
A study testing SIHT-16 in people with Dementia and Memory Impairment, run by Istanbul University at 1 site in Turkey (Türkiye).
Trial summary
An Adaptation Study of Free and Cued Selective Reminding Test in Turkish Read more about this study
- Who is it for?
- Any ageHealthy volunteers can take part
- Conditions the study is for
- Dementia, Memory Impairment
- What is being tested?
- SIHT-16
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 285 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 5 Jan 2020to 2 Apr 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- Healthy volunteers accepted
- Child, Adult, Older adult
Who may be able to join
- having memory complaints
- demanding clinical consultation for the memory complaint
Who cannot join
- vascular pathology
- extrapyramidal findings
- psychiatric illness
- epilepsy
- cognition affecting drug use
Trial locations and contacts
1 site in 1 country.
About this study
An Adaptation Study of Free and Cued Selective Reminding Test in Turkish
Read the detailed description
As very commonly used for objectifying Alzheimer Disease memory deficits, an adaptive selection of word choices are done for the use of free and cued selective reminding test (FCSRT) procedure in Turkish population. In this study the validity and reliability of the test to measure memory deficits in persons with memory complaints will be discussed.
- Conditions
- Dementia, Memory Impairment
- Being tested
- SIHT-16
- Keywords
- Alzheimer Disease, Memory Complaint, Memory, Dementia, Free and Cued Selective Reminding Test, Adaptation, Validity
- Medical subject headings
- Dementia, Memory Disorders, Alzheimer Disease
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
SIHT-16Behavioural
a pencil-paper assessment tool.
| Study group | Role | What they receive |
|---|---|---|
| Turkish Adaptation Study of Free and Cued Selective Reminding Test (SIHT-16) | Experimental | Outcomes of Turkish adaptation of Free and cued selective reminding test (SIHT-16) is compared with memory and non-memory test in three alternative lists: a,b, and c parallel lists. The participants are assessed in neurological diagnosis routine. Receives: Behavioral: SIHT-16 |
What is being measured
The primary outcome is the main question the study is designed to answer.
Validity of translation
Variances of answers given to each form will be compared to each other to know if they are similar or different.
Measured: once
Factor Analyses
Factor Analyses must be conducted to redefine the weight of each item on measuring memory deficits to be sure that turkish words version is similar to original factor weights.
Measured: once
Validity of the ability of the measure to objectify the memory deficit in dementia
Test measures must be sensitive enough to objectify a memory deficits even in early stages of dementia. The scores of memory test in early and late stages of dementia will be compared to see if they are different. It's expected to be different.
Measured: once
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted6 Mar 2023
- Study start5 Jan 2020
- Primary completion26 Dec 2024
- Study completion2 Apr 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for DementiaStudies of the same condition, open and under way.
- More trials run by Istanbul UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Screening
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 285 participants (actual)
Sponsor and investigators
- Lead sponsor
- Istanbul University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Jbid DURSUN UNCU, Istanbul University
- Investigators
- İ. Hakan Gürvit, Prof. MD., Study director, Istanbul University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05756231
- Sponsor's protocol ID
- 2019/778
- Acronym
- FCSRT-T
- Status last verified
- Apr 2025
- First submitted
- 26 Jan 2023
- Last updated
- 4 Apr 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 4 Apr 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Cultural and Linguistic Adaptation and Normative Study of the Turkish Version of the Free and Cued Selective Reminding Test: 16-Word Version (FCSRT-T)
- ClinicalTrials.gov ID
- NCT05756231
- Acronym / sponsor ID
- FCSRT-T / 2019/778
- Conditions
- Dementia, Memory Impairment
- Keywords
- Alzheimer Disease, Memory Complaint, Memory, Dementia, Free and Cued Selective Reminding Test, Adaptation, Validity
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 285 participants (actual)
- Lead sponsor
- Istanbul UniversityUniversity, hospital or other
- Study start
- 5 Jan 2020 (actual)
- Primary completion
- 26 Dec 2024 (actual)
- Study completion
- 2 Apr 2025 (actual)
- First posted
- 6 Mar 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
An Adaptation Study of Free and Cued Selective Reminding Test in Turkish
Detailed description
As very commonly used for objectifying Alzheimer Disease memory deficits, an adaptive selection of word choices are done for the use of free and cued selective reminding test (FCSRT) procedure in Turkish population. In this study the validity and reliability of the test to measure memory deficits in persons with memory complaints will be discussed.
Study design
- Primary purpose
- Screening
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Turkish Adaptation Study of Free and Cued Selective Reminding Test (SIHT-16) | Experimental | Behavioral: SIHT-16Outcomes of Turkish adaptation of Free and cued selective reminding test (SIHT-16) is compared with memory and non-memory test in three alternative lists: a,b, and c parallel lists. The participants are assessed in neurological diagnosis routine. |
Who may qualify
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (2 listed)
- having memory complaints
- demanding clinical consultation for the memory complaint
Key exclusion criteria (5 listed)
- vascular pathology
- extrapyramidal findings
- psychiatric illness
- epilepsy
- cognition affecting drug use
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| SIHT-16a pencil-paper assessment tool. | Behavioural | Turkish Adaptation Study of Free and Cued Selective Reminding Test (SIHT-16) |
Primary outcome
Validity of translation
Time frame: once
Variances of answers given to each form will be compared to each other to know if they are similar or different.
Factor Analyses
Time frame: once
Factor Analyses must be conducted to redefine the weight of each item on measuring memory deficits to be sure that turkish words version is similar to original factor weights.
Validity of the ability of the measure to objectify the memory deficit in dementia
Time frame: once
Test measures must be sensitive enough to objectify a memory deficits even in early stages of dementia. The scores of memory test in early and late stages of dementia will be compared to see if they are different. It's expected to be different.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 4 Apr 2025.
- Individual participant dataSharing planned: No
Related trials for Dementia
RecruitingPhase 2
Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin
Alzheimer's Disease
Not yet recruiting
Acupressure as Long-term Intervention to Slow the Progression of Early/Mild Alzheimer's Disease
Alzheimer's Disease
RecruitingObservational study
Effectiveness and Safety of Disease-Modifying Therapy for Alzheimer's Disease: A Multicenter Retrospective Study
Alzheimer's Disease (AD)
Not yet recruitingPhase 2
Lisdexamfetamine For the Treatment of Conduct Disorder in Children
Conduct Disorder
RecruitingPhase 3
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
Alzheimer Disease
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
İ. Hakan Gürvit, Prof. MD. study director
Istanbul University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing SIHT-16 in people with Dementia and Memory Impairment, run by Istanbul University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 4 Apr 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Validity of translation (time frame: once). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Apr 2025.